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Wiskott-Aldrich Syndrome Protein
Regulates Lipid Raft Dynamics
during Immunological Synapse Formation
is folded into a closed autoinhibited conformation with
the functional VCA region being masked by interaction
with the regulatory regions. Unmasking of the VCA re-
gion occurs upon synergistic binding of the lipid sec-
ond messenger, phosphatidylinositol 4.5-bisphosphate
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interaction with the WASP-interacting protein, WIP (Mar-Piazza Polonia 94
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SH3 domain-containing proteins (Nck, Grb2, Src, andItaly
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The specificity of WASP activation through Cdc42 im-Summary
plies that it mostly controls actin polymerization for the
formation of filopodia and membrane protrusions at theImmunological synapse assembly relies on the clus-
leading edge of hematopoietic cells (Nobes and Hall,tering of lipid rafts and is required for optimal T cell
1995; Symons et al., 1996) to which WASP expressionactivation. We demonstrate that the Wiskott-Aldrich
is restricted (Derry et al., 1994). In agreement, hemato-syndrome protein (WASP) is recruited to lipid rafts
poietic cells from WASP-deficient patients are alteredimmediately after TCR and CD28 triggering and is re-
in several functions including chemotaxis (Badolato etquired for the movements of lipid rafts. T cells from
al., 1998; Binks et al., 1998; Haddad et al., 2001), adhe-Wiskott-Aldrich syndrome (WAS) patients, lacking
sion (Linder et al., 1999), and phagocytosis (Linder et al.,WASP, proliferate poorly after TCR/CD28 activation
2001). However, the role of WASP during T cell activationand have impaired capacities to cluster the lipid raft
remains unclear. The hallmark of T cells from WAS pa-marker GM1 and to upregulate GM1 cell surface ex-
tients and WASP-deficient mice is a defective prolifera-pression. T cell proliferation and lipid raft clustering
tion after TCR stimulation (Molina et al., 1993; Gallegoare restored by retroviral transfer of the WASP gene.
et al., 1997; Snapper et al., 1998; Zhang et al., 1999). ThisThese results demonstrate that WASP plays a central
defect appears to be predominant in the pathogenesis ofrole in the movements of lipid rafts and identify a po-
WAS since the severity of the disease is directly relatedtential mechanism underlying the T cell defect affect-
to the residual full-length WASP expression levels in Ting WAS patients.
cells (Shcherbina et al., 1999). Consistently, a recently
described case of spontaneous reverse mutation re-Introduction
stricted to T cells showed a correction of T cell defects
accompanied by a clear amelioration of the clinical con-Wiskott-Aldrich syndrome (WAS) is an X-linked reces-
ditions (Wada et al., 2001).sive disorder characterized by thrombocytopenia, ec-
Defective TCR capping was described in WASP
zema, and immunodeficiency (Nonoyama and Ochs,
knockout mice (Zhang et al., 1999; Krawczyk et al.,
1998) which is due to mutations in the gene encoding
2000). In addition, WASP has been shown to be recruited
for the WAS protein (WASP). WASP belongs to a family to the site of contact between the T cell and the antigen-
of proteins that control de novo nucleation of actin fila- presenting cell (APC) (Krause et al., 2000; Cannon et
ments. Similar to WASP, N-WASP, Scar isoforms, Bee1, al., 2001). These data suggest that WASP may either
and Act-A act through regulated activation of the seven- promote or stabilize the organization of the immunologi-
subunit Arp2/3 complex to initiate nucleation of actin cal synapse that forms at the junction between the T
branches on the side of preexisting filaments (Higgs and cell and the APC during antigen presentation. The immu-
Pollard, 2000; Kim et al., 2000; Rohatgi et al., 2000; nological synapse consists of a central cluster of T cell
Machesky et al., 1999; Li, 1997; Welch et al., 1998). The receptors (TCRs) and costimulatory molecules, includ-
molecular basis for WASP activity relies on the confor- ing CD28 which is required for optimal T cell activation.
mational interplay between the COOH-terminal side that Adhesion molecules like LFA-1 and large glycoproteins
contains the functional VCA (verprolin/cofilin/acidic do- like CD43 and CD45 appear to form a ring around the
mains) region, necessary for both recruitment of actin centrally clustered TCRs (Monks et al., 1998; Grakoui et
monomers and activation of Arp2/3, and the NH2 termi- al., 1999; Dustin and Cooper, 2000). The formation of
nal and central part of the protein sequence that contain the immunological synapse is a dynamic process which
the regulatory regions, including the GTPase binding involves the clustering of lipid rafts (Simons and Ikonen,
domain. In the absence of upstream activators, WASP 1997) acting as membrane platforms which ensures that
TCRs move laterally together with their associated ki-
nases (Xavier et al., 1998; Viola et al., 1999). The aggre-4 Correspondence: m.roncarolo@hsr.it
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gating protein agrin (Khan et al., 2001), as well as cy-
toskeleton proteins including myosin motor proteins
(Wu¨lfing and Davis, 1998) and actin (Gomez-Mouton et
al., 2001; Valensin et al., 2002), are involved in this dy-
namic plasma membrane reorganization. However, it is
still unknown as to how lipid rafts interact with cytoskel-
eton proteins and how the movements of lipid rafts are
regulated during T cell activation and immunological
synapse formation.
To elucidate the role of WASP in immunological syn-
apse formation, we investigated the partition of this pro-
tein into lipid rafts during TCR activation. We show here
that WASP is recruited to lipid rafts within seconds after
TCR/CD28 activation. Using T cells from WASP-defi-
cient patients prior to and after transduction with a ret-
roviral vector containing the WASP gene, we found that
WASP is required for upregulation of the lipid raft marker
GM1 to the plasma membrane during T cell activation
and for clustering of lipid rafts at the site of immunologi-
cal synapse formation. Our study indicates that during
T cell activation WASP is required for the dynamics of
lipid rafts which are necessary for immunological syn-
apse assembly.
Results
WASP Is Recruited to Lipid Rafts Immediately
after TCR/CD28 Activation
Lipid rafts defined as detergent-insoluble membranes Figure 1. Kinetics of LAT, WASP, and CD3 Distribution in Lipid
were prepared from untransformed human T cell lines Rafts
derived from normal donors. The adaptor molecule T cells from normal donors were activated through TCR/CD28 for
the indicated periods of time. Following mild lysis preserving lipidlinker for activation of T cells (LAT) was used as a protein
raft integrity, sucrose density gradients were established, and singlemarker for lipid raft isolation (Zhang et al., 1998). Figure
fractions from these gradients (fraction 1 has the lowest density1 shows that, independently of TCR activation, LAT dis-
and fraction 8 has the highest) were analyzed for protein content.tributed in fractions 1, 2, and 3 of the gradient. In resting Western blot analysis was performed with mAbs against LAT, WASP,
T cells, WASP distributed in the gradient fractions 5, and CD3. One representative experiment out of three performed
6, 7, and 8, and it was excluded from the low-density is shown.
fractions corresponding to lipid rafts (Figure 1). This
distribution is in agreement with the cytosolic localiza-
WASP Lowers the Threshold for TCR/CD28-Drivention of WASP (Derry et al., 1994). TCR/CD28 activation
Proliferationof T cell lines induced the recruitment of WASP to lipid
The role of WASP in TCR/CD28-mediated T cell activa-rafts. This recruitment was observed as soon as 10 s
tion was investigated in untransformed T cell lines estab-after activation. The association of WASP to the lipid
lished from three unrelated Wiskott-Aldrich syndromeraft fraction was sustained over time, since it persisted
(WAS) patients. Western blot analysis showed that nonefor at least 5 min (Figure 1). Under the solubilization
of the three T cell lines from the WAS patients displayedconditions used, only a fraction of WASP was detected
detectable levels of WASP prior to stimulation (Figurein the lipid raft fractions upon activation.
2A). After TCR activation, very low levels of WASP wereTCR stimulation-dependent recruitment of CD3 to
detected in T cells from the WAS3 patient, carrying alipid rafts has been reported previously (Montixi et al.,
minor mutation resulting in a single amino acid substitu-1998, Xavier et al., 1998). We show here that the kinetic
tion, but not in T cells from WAS1 and WAS2 patients,of CD3 recruitment to lipid rafts is comparable to that
carrying more extensive mutations (Figure 2B). The de-of WASP (Figure 1). In addition, we observed that in
tection of the mutated protein from the WAS3 patientparallel to its recruitment to lipid raft fractions, CD3was
upon activation could either be due to an increaseddetected in the pellet of the gradient (data not shown).
interaction with partner molecules preventing its degra-Association of WASP with the lipid rafts was specific
dation or to the recruitment of the protein into lipid raftssince the cytosolic protein Cdc42, one of the activators
which could favor its stabilization.of WASP, was not present in the low-density fraction
Consistent with previous results obtained with bothunder the same activation conditions (data not shown).
human and murine T cells (Molina et al., 1993; GallegoPrevious data obtained by fluorescence microscopy
et al., 1997; Snapper et al., 1998; Zhang et al., 1999),analysis showed a Cdc42-independant WASP polariza-
the proliferative responses of WASP-deficient T cell linestion at the interface with the APC (Cannon et al., 2001).
upon activation with optimal doses of plastic-boundOur results indicate that lipid rafts could be the site of
anti-CD3 mAbs were strongly reduced compared tothis polarization and demonstrate that this phenomenon
occurs as an early event after TCR activation. those of T cell lines obtained from normal donors (ND)
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Figure 2. Defective WASP Expression and
Retroviral Vector-Mediated WASP Reexpres-
sion in WAS Patients’ T Cells
Western blot analysis of WASP expression in
WAS patients’ T cell lines (WAS1, WAS2, and
WAS3) and in normal donors’ T cell lines
(ND1, ND2, and ND3) in resting state (A) and
24 hr after activation with 10 g/ml immobi-
lized anti-CD3 mAbs (B). (C) WASP expres-
sion in ND1 T cell lines and in WAS1 patient T
cell lines either untransduced (U), transduced
with a control vector (C), or transduced with
a WASP-encoding retroviral vector (W).
(Figure 3A). However, at high concentrations of anti- WASP plays a crucial role in lowering the threshold for
TCR-driven proliferation. The defective T cell activationCD3 mAbs, WAS T cell lines displayed low but significant
proliferative responses (Figure 3A), suggesting that observed with optimal doses of plastic-bound anti-CD3
mAbs was not due to a reduced availability of TCR mole-
cules, since the basal levels of TCR expression and its
downregulation after activation (Figure 3B) were similar
in patients and normal cells. These results suggest that
the absence of WASP does not completely block the
signaling pathways downstream of the TCR but rather
prevents an amplification mechanism required for opti-
mal TCR activation.
Costimulation is essential for amplifying TCR-medi-
ated activation (Shahinian et al., 1993). To determine
whether WASP-deficient T cell lines could proliferate
after CD28-dependent costimulation, we used beads
coated with various doses of anti-CD3 mAbs and anti-
CD28 mAbs. This activation system mimics APCs in
driving the polarization of molecules associated with the
TCR activation complex (Viola et al., 1999; Krause et
al., 2000; Cannon et al., 2001) and leading to efficient
proliferation (Levine et al., 1996). Accordingly, we ob-
served that after activation with beads coated with anti-
CD3 mAbs and anti-CD28 mAbs, proliferation of normal
T cells was strongly increased in comparison to that
induced by anti-CD3 mAbs alone (Figures 3C and 3D).
However, as shown in Figure 3D, proliferation of WAS
T cells after stimulation with anti-CD3 mAbs- and anti-
CD28 mAbs-coated beads remained significantly im-
paired, as compared to the proliferation of normal cells
(p 0.05 t test for WAS1 and WAS2 T cell lines compared
to each of the control T cell lines, at every anti-CD3 mAb
Figure 3. Defective Proliferation of WAS Patients’ T Cells after TCR/ concentrations; p  0.05 t test for WAS3 T cell lines at
CD28 Triggering anti-CD3 mAb concentrations of 0.01 and 0.1 g/ml).
Proliferation and surface TCR expression of normal donors (filled To confirm that the proliferative defect in patients’ T
symbols: , ND1; , ND2; , ND3) and WAS patients’ (empty sym- cells was a direct consequence of the absence of WASP,
bols: , WAS1; , WAS2; , WAS3) T cell lines after increasing
WASP gene transfer was performed in T cell lines fromdoses of anti-CD3 mAbs with or without anti-CD28 mAbs. Prolifera-
WAS patients. After transduction with a WASP-encodingtion is expressed as cpm values corresponding to 3H-thymidine
retroviral vector, patient T cells were found to expressuptake after 72 hr stimulation. The levels of surface TCR expression
are expressed as the percentage of cells staining positive for the WASP protein at the expected molecular weight as
TCR/ 4 hr after stimulation. Proliferation (A) and TCR downregula- shown in Figure 2C for WAS1 patient. As illustrated in
tion (B) were tested in normal donors and WAS patients’ T cell lines Figure 3E, WASP expression in these cells resulted in
after stimulation with the indicated doses of immobilized anti-CD3
restoration of proliferation in response to TCR/CD28mAbs. Proliferation of normal donors and WAS patients’ T cell lines
activation (p  0.01 t test for the anti-CD3 mAb doseswas measured after stimulation with beads coated with different
0.1 and 1 g/ml). These results demonstrate that WASPconcentrations of anti-CD3 mAbs alone (C) or in combination with
10 g/ml anti-CD28 mAbs (D). Proliferation of T cells from patients is essential for optimal T cell proliferation following TCR/
WAS1 (H17009), WAS2 (), and WAS3 (), after WASP gene transfer is CD28 triggering.
compared to proliferation of untransduced ND3 (), untransduced
WAS1 (), WAS2 (), and WAS3 (), and mock-transduced WAS1
WASP Is Required for Lipid Raft Clustering(*) T cell lines after stimulation with beads coated with different
To investigate the role of WASP in aggregation of lipidconcentrations of anti-CD3 mAbs in combination with anti-CD28
mAbs (E). One representative experiment out of five is shown. rafts, we studied the redistribution of the GM1 glyco-
Immunity
160
Figure 4. Defective Clustering of Lipid Rafts
in T Cells Lacking WASP Expression
GM1 and F-actin distribution in normal do-
nors and WAS patients’ T cell lines activated
for 20 min with anti-CD3 mAb- plus anti-CD28
mAb-coated beads. (A) GM1 was specifically
stained with CtxB-FITC (a–c and g–i) and
F-actin with phalloidin-TRITC (d–f and j–l),
and the same cells are shown in parallel for
both stainings. (B) GM1 (a–c) and F-actin (d–f)
distribution in WAS1 patient’s T cells either
untransduced (U), transduced with a control
vector (C), or transduced with a WASP-
encoding retroviral vector (W). Localization of
the stimulatory beads is indicated by the
stars, and GM1 clusters at the cell to bead
contact are indicated by the arrows. An ex-
ample of results from one experiment out of
four is shown.
sphingolipid raft marker, using FITC-conjugated cholera (Figure 2B), had an intermediate phenotype with a signif-
icant fraction (39%) of cells showing focused redistribu-toxin subunit B (CtxB-FITC) that specifically binds to
GM1 (MacKenzie et al., 1997). Analysis by immunofluo- tion of GM1 at the area of contact with the beads (Figure
5A). However, the GM1 clusters observed in cells fromrescence microscopy was performed in T cells from
normal donors and WAS patients after 20 min stimula- the WAS3 patient were of lower intensity as compared
to those of normal cells (Figure 4Ai versus Figure 4Ac,tion with beads coated with anti-CD3 mAbs plus anti-
CD28 mAbs. F-actin redistribution, which is expected for example). F-actin reorganization was abrogated only
in a proportion of the cells from the WAS patients’ Tto be deficient in WAS patients T cells, was used as a
control by labeling the same cells with TRITC-conju- cell lines, the milder reduction being observed in WAS3
patient’s cells (Figure 5B). However, the typical tightgated phalloidin. In contrast to normal donors’ T cells
(Figures 4Aa–4Ac), T cells from WAS1 and WAS2 pa- F-actin collar at the contact with the antibody-coated
beads was not formed (Figures 4Aj–4Al versus Figurestients, which completely lack WASP expression, failed
to aggregate GM1 at the cell to bead contact area (Fig- 4Ad–4Af). This defect could result from the absence of
membrane protrusions around the beads as indicatedures 4Ag and 4Ah). Quantitative analysis indicated that
the percentages of cells displaying patched GM1 at the on Figure 4A. The observation that F-actin redistribution
was less severely affected than GM1 redistribution sug-bead contact area were severely reduced in T cell lines
from WAS1 and WAS2 patients, compared to the three gests that other molecules associated with F-actin reor-
ganization might partially compensate for the absencecontrol T cell lines (Figure 5A). T cells from WAS3 patient,
with detectable WASP expression upon TCR activation of WASP. As illustrated in Figure 5C, the percentages
Lipid Raft Defect in WAS Patients
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Figure 5. Restoration of Lipid Raft Clustering after WASP Gene
Transfer
Quantitative analysis of GM1 (A) and F-actin (B) clustering at the
area of contact with stimulatory beads was compared in T cells
from the three WAS patients, T cells from three normal donors,
and T cells from the three WAS patients transduced with a WASP-
encoding retroviral vector or after mock transduction (WAS1 T cells).
Cells were considered positive for clustered GM1 or clustered
F-actin if the staining was centered at the site of contact with the Figure 6. WASP Is Required for the Regulation of Lipid Raft Levels
bead and occupied less than one-third of the cell surface. Percent- at the Cell Surface
age of cells with GM1 and F-actin coclustering is also shown (C). Mean fluorescence intensity of CtxB-FITC surface staining of un-
Data are represented as mean percentages ( SD) of three experi- transformed T cell lines (A and B) and freshly isolated PBMC (C and
ments counting T cells in contact with a single bead with GM1 D) from normal donors (filled symbols: , ND1; , ND2; , ND3; H17009,
clusters, F-actin clusters, or both (for each cell line a total of 250 ND4; , ND5; H17009 ND6) and WAS patients (empty symbols: , WAS1;
to 300 cells was counted). , WAS2; , WAS3) after 72 hr stimulation with beads coated with
the indicated concentrations of anti-CD3 mAbs alone (A and C) or
in combination with 10 g/ml anti-CD28 mAbs (B and D). Analysis
was restricted to the cell population in contact with the beads asof cells with GM1 clustering and those of cells with
identified by the high FSC and SSC profile. One representative ex-coclustering of F-actin and GM1 were comparable, indi-
periment out of four is shown. (E and F) Mean fluorescence intensitycating that cells with a GM1 clustering defect also have
of CtxB-FITC corresponding to cell surface GM1 staining (white
a defect in F-actin clustering. The defect of lipid raft bars) and total GM1 staining (black bars) of alive untransformed T
clustering in patients’ T cells was directly due to the cell lines and fixed/permeabilized untransformed T cell lines, re-
spectively. Mean values of mean fluorescence intensity of WASabsence of WASP since after transduction with a WASP-
patients’ cell lines and normal donors’ cell lines are shown. Cellsencoding retroviral vector, lipid raft clustering was com-
were activated for 72 hr with beads coated with 10 g/ml anti-CD3pletely restored to the levels observed in normal donors
mAbs alone (E) or in combination with 10 g/ml anti-CD28 mAbscells (Figures 4Bc and 5). Overall, these results indicate
(F). One representative experiment out of three is shown.
that WASP is required for the movement of lipid rafts
leading to their aggregation and clustering.
stimulation (Lanzavecchia and Sallusto, 2000). Flow
cytometric analysis of the mean fluorescence intensityWASP-Defective T Cells Have Lower GM1 Levels
at the Cell Surface during T Cell Activation (MFI) of GM1-bound CtxB-FITC in resting cells revealed
that T cells from WAS1 and WAS2 patients (with noTo determine whether WASP regulates the cell surface
levels of lipid rafts, GM1 expression was measured in detectable WASP expression) express lower levels of
the lipid raft marker GM1, as compared to normal do-resting and activated WASP-defective T cells. The basal
level of plasma membrane lipid rafts, as determined by nors’ T cells (Figures 6A and 6B) (MFI: 49.7 for WAS1
and WAS2 patients’ T cells, and 123.2 for normal donors’cell surface expression of GM1 labeled with CtxB-FITC
(Viola et al., 1999) in resting T cells, may define the T cells; mean of five experiments, p 0.001 t test). After
72 hr activation with beads coated with high concentra-susceptibility of a T cell to activation, whereas the upreg-
ulation of lipid raft levels is a late event after T cell tions of anti-CD3 mAbs alone (Figure 6A) or anti-CD3
mAbs plus anti-CD28 mAbs (Figure 6B), WASP-deficientactivation, which may be required for sustained T cell
Immunity
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T cell lines showed a significantly (p  0.001 t test)
reduced capacity to upregulate their levels of surface
GM1 expression. A comparable defect in GM1 upregula-
tion was observed after stimulation with beads coated
with anti-CD3 mAbs with or without anti-CD28 mAbs of
freshly isolated peripheral blood lymphocytes from the
three WAS patients (Figures 6C and 6D, respectively).
Upregulation of cell surface GM1 during T cell activation
results from de novo GM1 synthesis in the Golgi appara-
tus and its translocation to the plasma membrane (Tu-
osto et al., 2001). To further investigate if the absence
of WASP results in a defect in total GM1 in the cells or
specifically in an impairment in the content of GM1 at
the plasma membrane, we measured by flow cytometry
the levels of surface GM1 and total GM1, which comprise
both surface and intracellular GM1. As shown in Figures
6E and 6F, at the resting state, both surface and total
GM1 levels were lower in patients’ cells as compared
to normal donors’ cells. However, the ratio of surface/
total GM1 was comparable in normal donor and WAS
patients’ T cells and was approximately 1:2. After activa- Figure 7. Defects in Calcium Influx after TCR Stimulation of WASP-
tion with beads either coated with anti-CD3 mAbs alone Deficient T Cells
(Figure 6E) or with anti-CD3 mAbs plus anti-CD28 mAbs Calcium mobilization of WAS patients’ T cells (left panels) and nor-
(Figure 6F), the total levels of GM1 remained lower in mal T cells (right panels), loaded with calcium-sensitive Fura-2 and
incubated with anti-CD3 mAbs (1 g/ml) plus anti-CD28 mAbs (1WASP-deficient T cells, compared to normal cells, sug-
g/ml) that were crosslinked by the addition of goat anti-mousegesting a possible defect in de novo synthesis or an
Abs where indicated. Analysis was performed by spectrofluorometryincreased degradation. However, the relative increase
and represented as percentage of fluorescence intensity after nor-in total GM1 in activated versus resting cells was not
malization for the amount of Fura-2 loaded in each cell line.
significantly different in normal T cells, as compared to
WAS T cells (2.2- and 2.5-fold, respectively, following
stimulation with anti-CD3 mAbs, and 3.1- and 2.1-fold, deficient T cells. In contrast, T cells from the WAS3
respectively, after stimulation with anti-CD3 mAbs plus patient, which display residual WASP expression and
anti-CD28 mAbs). On the other hand, in normal T cells modest defects in GM1 clustering, showed a calcium
most of the GM1 content was at the cell surface after influx comparable to normal cells. These data indicate
activation, whereas surface GM1 did not significantly that WAS defect and the associated defective GM1
increase in WAS T cells (the ratios of surface/total GM1 level/clustering result in a defective signaling at the level
for normal T cells and WAS T cells were 1:1 and 1:2, of calcium influx.
respectively, after stimulation with anti-CD3 mAbs stim-
ulation, and 1:1.2 and 1:2.2, respectively, after stimula- Discussion
tion with anti-CD3 mAbs plus anti-CD28 mAbs). These
results show a defect in surface GM1 in WASP T cell The formation of the immunological synapse is essential
lines, suggesting that in the absence of WASP the trans- not only to amplify T cell activation and to allow sus-
port of newly synthesized GM1 from intracellular com- tained T cell stimulation but also to integrate signaling
partments to the cell surface is defective. Thus, WASP cascades originating from the simultaneous activation
deficiency can impair not only the spatial redistribution of a wide variety of receptors (Dustin and Cooper, 2000;
of lipid rafts at the cell surface immediately after TCR/ Lanzavecchia and Sallusto, 2000). Growing evidence
CD28 activation but also the regulation of the levels of supports the concept that the formation of the immuno-
the lipid raft marker GM1 at the plasma membrane. logical synapse is a dynamic process based on the costi-
mulation-driven clustering of lipid raft membrane micro-
domains acting as transportation platforms for T cellWASP-Defective T Cells Have Reduced Calcium
Influx after T Cell Activation receptors and signaling complexes (Montixi et al., 1998;
Wu¨lfing and Davis, 1998; Harder and Simons, 1999; ViolaTo investigate whether the defects in GM1 levels ob-
served in WAS patients’ T cells could significantly affect et al., 1999).
In the present study, we show that, following TCR/their signaling, we measured calcium influx after stimu-
lation with crosslinked soluble anti-CD3 and anti-CD28 CD28 activation, WASP is recruited to lipid rafts and is
required for their clustering, leading to immunologicalmAbs. As shown in Figure 7, reduced flux of intracellular
calcium was observed in WAS1 and WAS2 T cells, as synapse formation. In resting T cells, WASP was not
detected in isolated lipid rafts. A few seconds after TCR/compared to control T cells. At the maximal intracellular
calcium concentration reached by WAS1 and WAS2 T CD28 activation, WASP was recruited to lipid rafts, indi-
cating that it must act very early during activation. Thiscells, a reduction of 29% and 47%, respectively, was
observed as compared to control T cells. In addition, finding is in line with the observation that WASP polar-
izes within a few minutes at the APC:T cell contactas it is illustrated in Figure 7, the area under the curve
of the calcium response was reduced in the WASP- (Krause et al., 2000; Cannon et al., 2001). In contrast to
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the massive polarization of WASP observed by immuno- tyrosine phosphorylation of the WASP-deficient T cell
lines (from patients WAS1 and WAS2) were observed, asfluorescence (Krause et al., 2000; Cannon et al., 2001),
we found that the levels of WASP recruited to lipid rafts compared to normal T cells (data not shown). However,
levels of calcium influx after stimulation with anti-CD3represent only a minor fraction of its total cellular con-
tent. This could be due to the fact that, in contrast to and anti-CD28 mAbs were reduced in WASP-deficient
T cells from WAS1 and WAS2 patients, as compared tomost characterized proteins partitioning into lipid rafts,
WASP is neither a transmembrane protein nor a lipid- control T cells. In contrast, T cells from the WAS3 patient,
which display residual WASP expression and modestmodified protein, and its association to membrane mi-
crodomains is presumably through noncovalent interac- defects in GM1 clustering, showed a calcium influx com-
parable to normal cells. These results are different fromtion with lipids and proteins present in these domains.
Consistent with the recruitment of WASP to lipid rafts those described by Molina et al. (1993), who found no
calcium influx defect in two patients’ T cell lines. How-described in this study, the WASP activators Vav-1 and
PIP2 were reported either to be associated to lipid rafts ever, this discrepancy could be due to the fact that the
intensity of the defect is variable from patient to patient,or to be recruited to them upon cell activation (Xavier
et al., 1998). On the other hand, the WASP activator as we observed. The calcium influx defect we report is
in accordance with the data in the WASP-KO murineCdc42, which is not required for the polarization of
WASP (Cannon et al., 2001), was found not to be re- model showing a reduced calcium influx in T cells. Thus,
these results indicate that WAS defect and the associ-cruited to lipid rafts after T cell activation. Taking into
account that F-actin polarization is necessary for lipid ated defective GM1 level/clustering significantly affect
signaling, specifically at the level of calcium influx.raft reorganization (Gomez-Mouton et al., 2001; Valensin
et al., 2002), we propose that WASP provides a physical The defect in lipid raft dynamics, which comprises
impaired transport and clustering, was shown in un-and functional link between lipid rafts and the actin cy-
toskeleton. Furthermore, our results demonstrate that transformed T cells derived from WAS patients affected
by a severe immunodeficiency. Therefore, we hypothe-the clustering of lipid rafts is directly controlled by WASP
since it was defective in WASP-deficient patients’ T size that these defects play a role in the dysfunction of
WAS patients’ T cells. Indeed, a defect in immunologicalcells, and it was restored by retroviral gene transfer of
WASP in these cells. Together, these data indicate that synapse assembly is consistent with the inability of
WASP-deficient T cells to proliferate after optimal stimu-WASP integrates multiple signals to promote actin net-
work formation at the contact with lipid raft membrane lation through the TCR and CD28, which was reported
for all WAS patients studied. The defective T cell activa-microdomains thus allowing their redistribution to sus-
tain assembly of the immunological synapse. tion observed with optimal doses of immobilized anti-
CD3 mAbs was not due to a reduced availability of TCRIn addition to a role in lipid raft aggregation, we show
that WASP is required for the normal expression of the molecules, since TCR internalization after activation was
similar in WAS patients’ cells and normal cells. TheseGM1 glycosphingolipid raft marker and for its cell sur-
face expression after stimulation. The levels of lipid raft findings differ from those obtained in the mouse WASP-
KO model in which a defective TCR internalization wasexpression have been shown to increase during T cell
maturation from naive toward memory phenotype (Tu- reported (Zhang et al., 1999). These discrepancies can
be explained by the different experimental conditionsosto et al., 2001). Therefore, the reduction in basal levels
of GM1 observed in freshly isolated WASP-deficient T used in the two studies.
At high concentrations of anti-CD3 mAbs alone, orcells may be related to their naive phenotype. However,
low basal levels of GM1 were also detected in in vitro anti-CD3 mAbs plus anti-CD28 mAbs, the proliferative
defect in WAS T cells could be partially overcome, sug-cultured T cell lines, which no longer express the
CD45RA naive marker (our unpublished data). Further- gesting that strong stimulation can bypass, to some
extent, the requirement for WASP and for a lipid raft-more, in contrast to normal cells, freshly isolated T cells
and cultured T cell lines from WAS patients showed a mediated receptor clustering. Thus, WASP lowers the
threshold for proliferation and is required for responsesprofound defect in their capacity to upregulate their
levels of surface GM1 expression after TCR/CD28 stimu- to optimal concentrations of anti-CD3 and anti-CD28
mAbs. Indeed, T cell proliferation after optimal TCR/lation. This impaired transport of GM1 to the plasma
membrane in WASP-deficient T cells could be due to CD28 stimulation was restored in WAS T cells trans-
duced with retroviral vector encoding for the WASPthe requirement of WASP for the efficient movement of
lipid rafts to the cell surface. This can occur thanks to gene. These results demonstrate that WASP is required
for the TCR/CD28-dependent proliferation of T cells andthe ability of WASP to provide a physical link between
lipid rafts and the actin cytoskeleton. On the other hand, are in agreement with studies in the mouse WASP
knockout model indicating that WASP acts downstreamit is possible that the absence of WASP leads to a defect
in the signaling cascade controlling the lipid raft trans- of CD28 through Vav-1 and Cdc42 activation (Krawczyk
et al., 2000). Vav-1, a guanine nucleotide exchange fac-port. In addition, a defect in GM1 de novo biosynthesis
or an increased degradation of GM1 could also occur tor for Rho GTPases, is one of the main effectors of CD28
and, like WASP, is required for IL-2 gene activation, actinin WASP-deficient T cells.
In order to link lipid raft defects to downstream signal- cytoskeleton reorganization, and TCR capping (Michel
et al., 2000).ing defects, we investigated TCR-induced tyrosine
phosphorylation and calcium influx in WAS patients’ T The defective cell surface expression and reorganiza-
tion of lipid rafts during activation of WAS patients’ Tcells. As described earlier for WAS patients’ T cells (Mo-
lina et al., 1993) and WASP-KO mouse T cells (Zhang cells may be specifically responsible for the inability
to develop antigen-specific immune responses and toet al., 1999), no notable differences in the pattern of
Immunity
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bating them with anti-NLGFR mAbs (ATCC, Rockville, MD) andbuild up specific memory responses. A remaining ques-
purifying them with rat anti-mouse IgG1-coated magnetic beadstion is whether the absence of WASP-controlled spatial
(Dynabeads M-450, Dynal AS, Oslo, Norway). After two rounds ofdynamics of lipid rafts is responsible, in WAS patients,
immunoselection, over 90% of the cells expressed the LNGFR
for the impairment of other immunological functions me- marker and were found to express full-length WASP. Proliferative
diated by hematopoietic cells, including chemotaxis response and lipid raft clustering were studied in recently generated
transduced T cell lines since in some lines the stability of WASP(Badolato et al., 1998; Binks et al., 1998; Haddad et al.,
expression decreased after repeated stimulation.2001), adhesion (Linder et al., 1999), and phagocytosis
(Linder et al., 2001).
Beads Preparation
Five micron diameter latex beads (Interfacial Dynamics Corp., Port-Experimental Procedures
land, OR) were coated with the indicated concentrations of anti-
CD3 mAbs and anti-CD28 mAbs in phosphate-buffered saline (PBS)Patients
at 4C overnight. Antibody-coated beads were washed twice in PBSThe three WAS patients described here have a typical clinical pheno-
containing 2% FCS and saturated for 30 min in complete mediumtype and mutation analysis which confirmed the WAS diagnosis.
prior to mixing with the T cells. The culture conditions were compa-The WAS1 patient has a 4 nucleotide deletion (tgag) at intron 9
rable to those described above.splice donor site of the WASP gene (position 	2 to 	5). The WAS2
patient carries a 2 nucleotide deletion (ag) in exon 4 (position 484
Proliferation Assay and Analysis of TCR Downregulationto 485) resulting in a stop codon (codon 167). The WAS3 patient
Resting T cells (9 to 14 days poststimulation with feeder cell mixture)carries a single nucleotide mutation in exon 3 (t348c) resulting in a
were harvested, centrifuged, and incubated overnight at 2 
 106L105P amino acid substitution. None of the patients received bone
per ml in fresh medium without cytokine. They were plated at 1
 105marrow transplantation because no HLA-compatible donors were
cells/well in 96-well flat-bottom plates precoated with the indicatedavailable. Blood samples from WAS patients were obtained follow-
dose of anti-CD3 mAbs. Alternatively, cells were plated at 5 
 104ing standard ethical procedures.
per well on 96-well U-bottom plates in a final volume of 100 l, and
100 l of mAbs-coated beads was added at a 2:1 bead to cell ratio.T Cell Lines
After 72 hr, cells were labeled with 3H-thymidine for 18 hr. ThymidineUntransformed T cell lines from WAS patients and normal donors
incorporation was measured in triplicates by liquid scintillationwere derived from PBMC isolated on Lymphoprep (Nycomed Pharma
counting. TCR downregulation was measured by FACS staining ofAS, Oslo, Norway) gradient and generated as described previously
surface molecules on T cells (with FITC-conjugated anti-TCR/(Bacchetta et al., 1993). In brief, PBMC were stimulated at a concen-
Abs, Caltag Laboratories) 4 hr after activation with the indicatedtration of 2 
 105 cells/ml in a final volume of 1 ml in 24-well plates
doses of immobilized anti-CD3 mAbs. Results represent percent-by a feeder cell mixture which comprises irradiated allogenic PBMCs
ages of TCR/ positive cells.(1 
 106/ml), irradiated EBV-transformed JY cells (1 
 105/ml), PHA
(1 g/ml), IL-2 (100 IU/ml), IL-4 (10 ng/ml), and IL-7 (10 ng/ml). Cells
Immunofluorescencewere cultured in Yssel medium (Dyaclone, Besanc¸on, France), 10%
Cells in the resting phase were incubated overnight at 2 
 106 perFCS, and penicillin/streptamycin. Cells were expanded with feeder
ml in fresh medium without cytokine and then harvested and platedmixture every 2 weeks.
at 5 
 104 per well on 96-well U-bottom plates in a final volume of
100 l. One hundred microliters of mAbs-coated beads was addedLipid Raft Isolation and Immunoblotting
at a 2:1 bead to cell ratio. Plates were centrifuged for 10 s at 1500T cells (5 
 107 ) were used either resting or after TCR activation for
rpm and incubated for 20 min at 37C. Cell-bead complexes weredifferent periods of time with 10 g/ml anti-CD3 mAbs (OKT3 clone,
transferred onto poly-L-lysine-coated coverslips to allow attach-Janssen-Cilag) plus 1 g/ml anti-CD28 mAbs (CD28.2 clone, Phar-
ment for 2 min on ice. Fixation was performed by adding an equalMingen, Becton Dickinson), crosslinked with 33 g/ml goat anti-
volume of 4% paraformaldehyde and incubation for 30 min at roommouse Abs (Dako). T cells were washed twice with PBS, then resus-
temperature. Staining for GM1 and F-actin was performed by incu-pended in 900 l ice-cold buffer containing 2 mM Tris (pH 7.5), 150
bation with 8 g/ml FITC-conjugated cholera toxin subunit B (CtxB-mM NaCl, and 5 mM EDTA, and supplemented with a mixture of
FITC, Sigma) and 1.5 g/ml TRITC-conjugated phalloidin (Phall-protease inhibitors (Complete, Roche Molecular Biochemicals).
TRITC, Sigma) in PBS, 0.3% BSA, and 0.3% saponin. Staining wasBrij58 was added to a final concentration of 1%, and cells were
performed at room temperature for 45 min. After two washes inhomogenized with a Dounce homogenizer and incubated on ice for
PBS, coverslips were mounted with Fluoromount-G (Southern Bio-1 hr. The lysate was adjusted to 1.33 M sucrose and placed at the
technology Associates, Inc., Birmingham, AL) and analyzed by im-bottom of a 12 ml ultracentrifuge tube. A step gradient (from 0.2 to
munofluorescence microscopy.0.9 M) was layered, and the tubes were centrifuged for 16 hr at
39,000 rpm and at 4C in a SW41 rotor (Beckman Instruments Inc.).
Cell Surface and Total GM1 ExpressionOne milliliter fractions were harvested from the top, and proteins
Resting T cell lines or freshly isolated PBMC were stimulated withwere concentrated using a standard TCA precipitation protocol and
beads precoated with the indicated mAb concentrations. Surfacethen resuspended in denaturing SDS-PAGE sample buffer. Follow-
GM1 expression levels were assessed after staining with FITC-con-ing SDS-PAGE resolution, proteins were transferred onto nitrocellu-
jugated cholera toxin and flow cytometry analysis of the mean fluo-lose membranes and then incubated with specific antibodies. The
rescence intensity using a FACScan (Becton Dickinson). For mea-following Abs were used: anti-WASP, anti-LAT, and anti-CD3 (Santa
surement of total GM1 levels, specific staining was performed afterCruz Biotech., Santa Cruz, CA). HRP-coupled Abs (Amersham Phar-
fixation in 2% paraformaldehyde for 30 min at room temperaturemacia Biotech) were used as secondary Abs, and detection was
and permeabilization with PBS, 0.3% BSA, and 0.3% saponin forperformed either with ECL (Amersham Pharmacia Biotech) or Su-
15 min at room temperature. We show values obtained 72 hr afterperSignal (Pierce) detection systems.
TCR/CD28 stimulation since it corresponded to the maximal surface
GM1 staining reached. The mean MFI for surface CtxB stainingWASP Gene Transfer
of T cells was found to increase proportionally to the number ofThe Moloney murine leukemia virus-based vector-encoding WASP
restimulation in in vitro cultures. Data in Figures 6A and 6D were(LTR-LNGFR–SV40-WASP) was derived from the LNSN vector
obtained with cell lines at feeder 2, whereas in Figures 6E and 6F(Mavilio et al., 1994) by replacing the neoR gene with the WASP
cell lines at feeder 6 were used.cDNA downstream of the SV-40 promoter. A stable Am12-based
producer cell line (Markowitz et al., 1988) was established. Trans-
duction of WAS T cells was performed by two successive rounds Measurement of Calcium Influx
Resting T cells were resuspended at 2 
 106 per 0.5 ml of Krebs-of infection on retronectin-coated plates as described previously
(Pollok et al., 1998). Transduced cells were immunoselected by incu- Ringer HEPES medium (KRH: 125 mM NaCl, 5 mM KCl, 1.2 mM
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MgSO4, 2.2 mM KH2PO4, 25 mM HEPES/NaOH, 2 mM CaCl2, and Gallego, M., Santamaria, M., Pena, J., and Molina, I. (1997). Defective
actin reorganization and polymerization of Wiskott-Aldrich T cells6 mM glucose) and loaded with 2.5 M Fura-2 AM (Calbiochem) in
the presence of 50 M diethilenetriaminepentaacetic acid for 60 in response to CD3-mediated stimulation. Blood 90, 3089–3097.
min at 25C. Equal volume (0.5 ml) of KRH medium supplemented Gomez-Mouton, C., Abad, J.L., Mira, E., Lacalle, R.A., Gallardo, E.,
with 5% FCS was added for 15 min at 25C. T cells were washed Rimenez-Baranda, S., Illa, I., Bernad, A., Manes, S., and Martinez-A.,
and resuspended in ice-cold 200 l KRH medium supplemented C. (2001). Segregation of leading-edge and uropod components into
with 200 M sulfinpyrazone and containing 1 g/ml anti-CD3 and specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci.
1 g/ml anti-CD28 mAbs. After 15 min on ice, cells were washed, USA 98, 9642–9647.
resuspended in 1 ml KRH medium supplemented with 200 M sul-
Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S.,
finpyrazone, transferred into a thermostatted cuvette (37C), main-
Allen, P.M., and Dustin, M.L. (1999). The immunological synapse: a
tained under continuous stirring, and analyzed with a Perkin-Elmer
molecular machine controlling T cell activation. Science 285,
LS-5B fluorimeter. When a stable baseline was reached, 10 g/ml
221–227.
goat-anti-mouse Abs was added for crosslinking as indicated. Data
Haddad, E., Zugaza, J.L., Louache, F., Debili, N., Crouin, C.,are represented as normalized intensity of Fura-2 fluorescence as
Schwarz, K., Fischer, A., Vainchenker, W., and Bertoglio, J. (2001).described previously (Fasolato et al., 1991).
The interaction between Cdc42 and WASP is required for SDF-1-
induced T-lymphocyte chemotaxis. Blood 97, 33–38.Acknowledgments
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